The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pravafenix



Laboratoires SMB S.A.EU/1/11/679/001-006

Main Information

Trade NamePravafenix
Active SubstancesFenofibrate
Pravastatin sodium
Dosage FormCapsule, hard
Licence HolderLaboratoires SMB S.A.
Licence NumberEU/1/11/679/001-006

Group Information

ATC CodeC10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents
C10BA03 pravastatin and fenofibrate

Status

License statusAuthorised
Licence Issued14/04/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back